To issue task C06 task order award in the base amount of $388,097.

Ended Awarded Last action

Contract number
75N93019F00131
Awardee
Awarding agency
Obligated
$895,195

Award facts

Opportunity
  • NIHAI2016059 Solicitation number
Contract value 100% obligated
$895,195.11 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Galveston, TX 77555, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$284,467
Other Administrative Action P00006 · Dmid pcmid task area C06 $0
Exercise an Option P00005 · The purpose of this modification is to exercise quantity option 3. $197,906
Exercise an Option P00004 · The purpose of this modification is to exercise quantity option 1. $193,227
Other Administrative Action P00003 · To issue a no additional cost extension. $0
Exercise an Option P00002 · To exercise quantity option 4 in the amount of $202,690 and incorporate far clause 52.204-25, prohibition on contracting for certain telecommunications and… $202,690
Exercise an Option P00001 · To to exercise quantity option 2 in the amount of $197,742. $197,742
Original award $388,097

About this award

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded the University of Texas Medical Branch at Galveston (UTMB) a $388,097 delivery order task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. This contract is for pre-clinical models of infectious diseases research. The award has no set-aside designation. As a prime contractor, UTMB provides a range of medical research and public health services to federal agencies, including preclinical testing of HIV/AIDS and tuberculosis treatments, clinical trials, and high-consequence pathogen response training. UTMB has also received over $100 million in IDIQ contract funding and grants from NIH, CDC, and DOD for related initiatives, such as developing organ-chip models to test drug safety during pregnancy.

Quick answers

Who was awarded contract 75N93019F00131?

75N93019F00131 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 16, 2019.

How much is contract 75N93019F00131 worth?

The government has obligated $895,195 on 75N93019F00131.

Is contract 75N93019F00131 an order under another contract?

Yes. 75N93019F00131 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.

Was contract 75N93019F00131 competed?

The extent of competition for 75N93019F00131 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award